Skip to content
Screener

Bruker BRKR Other, net

Other, net at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
-$6M
Danaher logo
DanaherDHR
-$43M-10.3%
Mettler-Toledo International, Inc. logo
Mettler-Toledo International, Inc.MTD
$0+100%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
-$10M-11.1%

Other financials

Income statement

See full
Revenue$838.5M+5.2%
Gross profit$416.0M+16.2%
Operating income-$65.3M-649%
Net income-$52.0M-784%
EPS (diluted)-$0.41-920%

Balance sheet

See full
Cash & equivalents$189.1M+96.6%
Total debt$1.8B-25.1%
Total equity$2.4B+31.9%
Total assets$6.1B-4.5%

Cash flow

See full
Operating cash flow-$77.4M+39.3%
CapEx$28.8M+35.2%
Free cash flow-$106.2M+28.6%

Valuation

See full
Market cap$7.81B+67.9%
Enterprise value$9.45B+35.1%
P/S2.2×+0.9×

Profitability

See full
Gross margin46.4%-1.8pp
Operating margin-0.9%-6.2pp
Net margin-0.6%-10.0pp
FCF margin2.7%+1.3pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.8×-0.6×
Current ratio1.8×+0.2×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromPaymentsForOtherFinancingActivities.

The source filing: Bruker’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:09 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-211889
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Payment of dividends to Series A Mandatory Convertible Preferred Shareholders(11.0)
Payment of dividends to common shareholders(7.6)(7.7)
Repurchase of common stock(10.0)
Other financing activities, net(5.0)(0.7)
Net cash used in financing activities(204.9)(51.2)
Effect of exchange rate changes on cash, cash equivalents and restricted cash7.913.3
Net (decrease) increase in cash, cash equivalents and restricted cash(165.5)1.0
Cash, cash equivalents and restricted cash at beginning of period303.1186.7

ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is Bruker's other, net?
Bruker (BRKR) reported other, net of -$5M in Q1 2026.
How has Bruker's other, net changed year-over-year?
Bruker's other, net decreased by 614.3% year-over-year, from -$700K to -$5M.
What is the long-term trend for Bruker's other, net?
Over 2 years (2023 to 2025), Bruker's other, net has grown at a 426.0% compound annual growth rate (CAGR), from $300K to -$8.3M.
What does other, net mean?
Includes miscellaneous cash flows related to financing activities that are not categorized as debt issuance, dividends, or share repurchases. This may include changes in non-controlling interests, debt issuance costs, or other unique financing-related transactions. It provides a comprehensive view of non-standard financing cash movements.

Ask your AI about Bruker's other, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude